|
Name |
(1S,4aS,8aR)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(1S,4aS,8aR)-7-methyl-4-methylidene-1-propan-2-yl-2,3,4a,5,6,8a-hexahydro-1H-naphthalene
|
|
SMILES |
CC1=C[C@@H]2[C@H](CC1)C(=C)CC[C@H]2C(C)C
|
|
InChI |
InChI=1S/C15H24/c1-10(2)13-8-6-12(4)14-7-5-11(3)9-15(13)14/h9-10,13-15H,4-8H2,1-3H3/t13-,14+,15-/m0/s1
|
|
InChIKey |
WRHGORWNJGOVQY-ZNMIVQPWSA-N
|
|
Synonyms |
gamma-Muurolene; (+)-gamma-muurolene; (1S,4aS,8aR)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene; (1S,4aS,8aR)-7-methyl-4-methylene-1-(propan-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; (?)-gamma-Muurolene; 24268-39-1; CHEBI:64798; DTXSID401017737; C20273; Q27133437; (1S,4aS,8aR)-7-methyl-4-methylidene-1-propan-2-yl-2,3,4a,5,6,8a-hexahydro-1H-naphthalene
|
|
CAS | 24268-39-1 | |
PubChem CID | 12313020 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.524 |
Caco-2 Permeability: | -4.446 | MDCK Permeability: | 0.00001760 |
Pgp-inhibitor: | 0.023 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.993 |
30% Bioavailability (F30%): | 0.593 |
Blood-Brain-Barrier Penetration (BBB): | 0.496 | Plasma Protein Binding (PPB): | 94.60% |
Volume Distribution (VD): | 3.408 | Fu: | 4.73% |
CYP1A2-inhibitor: | 0.885 | CYP1A2-substrate: | 0.419 |
CYP2C19-inhibitor: | 0.496 | CYP2C19-substrate: | 0.845 |
CYP2C9-inhibitor: | 0.654 | CYP2C9-substrate: | 0.228 |
CYP2D6-inhibitor: | 0.025 | CYP2D6-substrate: | 0.199 |
CYP3A4-inhibitor: | 0.25 | CYP3A4-substrate: | 0.361 |
Clearance (CL): | 9.749 | Half-life (T1/2): | 0.06 |
hERG Blockers: | 0.099 | Human Hepatotoxicity (H-HT): | 0.269 |
Drug-inuced Liver Injury (DILI): | 0.687 | AMES Toxicity: | 0.05 |
Rat Oral Acute Toxicity: | 0.403 | Maximum Recommended Daily Dose: | 0.097 |
Skin Sensitization: | 0.175 | Carcinogencity: | 0.809 |
Eye Corrosion: | 0.257 | Eye Irritation: | 0.534 |
Respiratory Toxicity: | 0.803 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000800 | 1.000 | D04CSZ | 0.321 | ||||
ENC004008 | 0.673 | D02KIU | 0.227 | ||||
ENC002224 | 0.577 | D0V2JK | 0.223 | ||||
ENC002017 | 0.527 | D04ATM | 0.222 | ||||
ENC000762 | 0.489 | D0K5WS | 0.214 | ||||
ENC002199 | 0.464 | D0A2AJ | 0.213 | ||||
ENC000339 | 0.464 | D04GJN | 0.211 | ||||
ENC004007 | 0.435 | D06JPB | 0.210 | ||||
ENC001817 | 0.414 | D00YWP | 0.210 | ||||
ENC002553 | 0.414 | D0O1UZ | 0.209 |